Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-03-06 @ 6:19 PM
Study NCT ID:
NCT03207958
Status:
COMPLETED
Last Update Posted:
2024-03-13
First Post:
2017-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Sponsor:
Washington University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
201709068
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None